Interaction between Cefotaxime and Nystatin
Unknown
Unknown
ID | DDInter323 and DDInter1318 |
Interaction |
Amnesia
bronchiolitis
confusion
Cough
patent ductus arteriosis
ischaemia
black stools
narcolepsy
nystagmus
loss of consciousness
More
|
Management | - |
References | |
Alternative for Cefotaxime |
J01D
More
|
Alternative for Nystatin |
D01A
More
|
Potential Metabolism Interactions
Substrate-Substrate Interaction:If more than one drug is metabolized by the same CYP, it is possible that its metabolism is inhibited because of the competition between the drugs. That means, it can be useful to lower the dosage of the drugs in the drug-cocktail because they remain longer in the organism than in monotherapy.
Inhibitor-Inhibitor Interaction:Combining two or more inhibitors of one CYP, should be compensated by lowering the dosage of these drugs because the metabolism is reduced and the drugs remain longer in the organism than in monotherapy. Not adapting the dosage bears the risk of even more side effects.
Inhibitor-Substrate Interaction:Combining drugs that have inhibitory effect and are substrates of one particular CYP, should be compensated by lowering the dosage. They rest longer in the organism than in monotherapy. Not adapting the dosage bears the risk of even more side effects.